Equities analysts predict that Phibro Animal Health Corporation (NASDAQ:PAHC) will post earnings of $0.38 per share for the current quarter, according to Zacks. Zero analysts have made estimates for Phibro Animal Health Corporation’s earnings. The highest EPS estimate is $0.41 and the lowest is $0.36. Phibro Animal Health Corporation reported earnings of $0.36 per share in the same quarter last year, which indicates a positive year over year growth rate of 5.6%. The business is expected to announce its next quarterly earnings report after the market closes on Monday, November 6th.

On average, analysts expect that Phibro Animal Health Corporation will report full year earnings of $1.57 per share for the current financial year, with EPS estimates ranging from $1.55 to $1.60. For the next fiscal year, analysts anticipate that the business will post earnings of $1.68 per share, with EPS estimates ranging from $1.65 to $1.75. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side research analysts that follow Phibro Animal Health Corporation.

Phibro Animal Health Corporation (NASDAQ:PAHC) last posted its earnings results on Wednesday, August 30th. The company reported $0.39 EPS for the quarter, topping the Zacks’ consensus estimate of $0.35 by $0.04. Phibro Animal Health Corporation had a return on equity of 47.88% and a net margin of 8.45%. The business had revenue of $194.84 million for the quarter, compared to analysts’ expectations of $192.47 million. During the same quarter in the previous year, the firm earned $0.32 earnings per share. The business’s revenue was up 3.0% compared to the same quarter last year.

A number of brokerages have issued reports on PAHC. Bank of America Corporation reissued an “underperform” rating and issued a $33.00 target price on shares of Phibro Animal Health Corporation in a report on Wednesday, August 23rd. BidaskClub lowered shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 23rd. Piper Jaffray Companies set a $35.00 price target on shares of Phibro Animal Health Corporation and gave the company a “buy” rating in a research note on Friday, July 21st. Finally, Credit Suisse Group raised their price target on shares of Phibro Animal Health Corporation from $36.00 to $37.00 and gave the company an “outperform” rating in a research note on Thursday, August 31st. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $33.00.

ILLEGAL ACTIVITY NOTICE: “$0.38 Earnings Per Share Expected for Phibro Animal Health Corporation (PAHC) This Quarter” was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/10/24/0-38-earnings-per-share-expected-for-phibro-animal-health-corporation-pahc-this-quarter.html.

Phibro Animal Health Corporation (NASDAQ PAHC) remained flat at $37.30 during mid-day trading on Tuesday. The stock had a trading volume of 70,314 shares. The stock has a market capitalization of $1.49 billion, a PE ratio of 23.17 and a beta of 1.37. The stock has a 50 day moving average of $36.59 and a 200 day moving average of $35.58. Phibro Animal Health Corporation has a 52-week low of $24.85 and a 52-week high of $40.25.

In related news, VP Daniel M. Bendheim sold 4,976 shares of the firm’s stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $40.01, for a total value of $199,089.76. Following the completion of the transaction, the vice president now owns 4,176 shares of the company’s stock, valued at approximately $167,081.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Daniel M. Bendheim sold 5,938 shares of the firm’s stock in a transaction that occurred on Wednesday, August 16th. The stock was sold at an average price of $40.04, for a total transaction of $237,757.52. Following the completion of the transaction, the vice president now directly owns 300 shares of the company’s stock, valued at approximately $12,012. The disclosure for this sale can be found here. Insiders have sold 292,448 shares of company stock valued at $10,624,994 over the last 90 days. 51.88% of the stock is currently owned by insiders.

Several large investors have recently modified their holdings of PAHC. Mason Street Advisors LLC boosted its stake in shares of Phibro Animal Health Corporation by 7.1% during the 1st quarter. Mason Street Advisors LLC now owns 4,333 shares of the company’s stock valued at $122,000 after buying an additional 286 shares during the period. Victory Capital Management Inc. boosted its stake in shares of Phibro Animal Health Corporation by 79.2% during the 1st quarter. Victory Capital Management Inc. now owns 4,573 shares of the company’s stock valued at $129,000 after buying an additional 2,021 shares during the period. State of Alaska Department of Revenue boosted its stake in shares of Phibro Animal Health Corporation by 80.9% during the 2nd quarter. State of Alaska Department of Revenue now owns 3,690 shares of the company’s stock valued at $136,000 after buying an additional 1,650 shares during the period. Municipal Employees Retirement System of Michigan boosted its stake in shares of Phibro Animal Health Corporation by 3.6% during the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after buying an additional 150 shares during the period. Finally, KBC Group NV acquired a new stake in shares of Phibro Animal Health Corporation during the 2nd quarter valued at $166,000. 49.69% of the stock is owned by institutional investors.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Get a free copy of the Zacks research report on Phibro Animal Health Corporation (PAHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.